Tumor budding as an indicator of prognosis in locally advanced rectal cancer after neoadjuvant chemoradiotherapy: a systematic review and meta-analysis
IntroductionTumor budding (TB) is recognized as a complementary prognostic factor for colorectal cancer. However, data on its impact on the survival of patients undergoing neoadjuvant chemoradiotherapy (nCRT) remain limited. This study aims to investigate the role of TB in disease-free survival (DFS...
Saved in:
| Main Authors: | Azita Rafiee, Parto Nasri, Afshin Moradi, Paridokht Karimian |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1429319/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Complete histopathological regression in rectal cancer after neoadjuvant chemoradiotherapy and sphincter preserving surgical treatment
by: Petrović Tomislav, et al.
Published: (2018-01-01) -
Factors affecting survival prognosis of patients with rectal cancer after neoadjuvant chemoradiotherapy
by: Baokun Li, et al.
Published: (2025-05-01) -
Neoadjuvant chemoradiotherapy in combined treatment of patients with rectal cancer
by: N. A. Maistrenko, et al.
Published: (2017-08-01) -
Response Assessment after Neoadjuvant Chemoradiotherapy in Rectal Cancer
by: Anuradha Chandramohan, et al.
Published: (2025-05-01) -
The Influence of Neoadjuvant Chemoradiotherapy on Muscle Mass in Patients with Rectal Cancer
by: Gregory Simpson, et al.
Published: (2019-07-01)